Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 11, 2006, Pages 1049-1058

  Jones, David T W ^a   Ichimura, Koichi ^a   Liu, Lu ^a   Pearson, Danita M ^a   Plant, Karen ^a   Collins, V Peter ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

aCGH; Aneuploidy; Pilocytic astrocytoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; CHROMOSOME 3; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FISHER EXACT TEST; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE FREQUENCY; GENOMICS; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RANK SUM TEST; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MICROGLIA; MICROSATELLITE REPEATS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33750592886     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000240465.33628.87     Document Type: Article

References (61)

1. Office for National Statistics. The Health of Children and Young People. March 31, 2004. Available at: www.statistics.gov.uk/children/. Accessed June 2, 2005
2. Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System: World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2000
3. Central Brain Tumour Registry of the United States. Statistical Report: Primary Brain Tumours in the United States, 1997-2001. Chicago: CBTRUS, 2005
4. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64:479-89
5. Claus D, Sieber E, Engelhardt A, et al. Ascending central nervous spreading of a spinal astrocytoma. J Neurooncol 1995;25:245-50
6. Kleinman GM, Schoene WC, Walshe TM III, et al. Malignant transformation in benign cerebellar astrocytoma. Case report. J Neurosurg 1978;49:111-18
7. Tomlinson FH, Scheithauer BW, Hayostek CJ, et al. The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: A clinicopathologic and flow cytometric study. J Child Neurol 1994;9:301-10
8. Krieger MD, Gonzalez-Gomez I, Levy ML, et al. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 1997;27:1-11
9. Dirven CM, Mooij JJ, Molenaar WM. Cerebellar pilocytic astrocytoma: A treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst 1997;13:17-23
10. Giannini C, Scheithauer BW. Classification and grading of low-grade astrocytic tumors in children. Brain Pathol 1997;7:785-98
11. Aldape K, Simmons ML, Davis RL, et al. Discrepancies in diagnoses of neuroepithelial neoplasms: The San Francisco Bay Area Adult Glioma Study. Cancer 2000;88:2342-49
12. Agamanolis DP, Malone JM. Chromosomal abnormalities in 47 pediatric brain tumors. Cancer Genet Cytogenet 1995;81:125-34
13. Bhattacharjee MB, Armstrong DD, Vogel H, et al. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 1997;97:39-53
14. Bigner SH, McLendon RE, Fuchs H, et al. Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet 1997;97:125-34
15. Blaeker H, Rasheed BK, McLendon RE, et al. Microsatellite analysis of childhood brain tumors. Genes Chromosomes Cancer 1996;15:54-63
16. Debiec-Rychter M, Alwasiak J, Liberski PP, et al. Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases. Cancer Genet Cytogenet 1995;85:61-67
17. Jenkins RB, Kimmel DW, Moertel CA, et al. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 1989;39:253-79
18. Ransom DT, Ritland SR, Kimmel DW, et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 1992;5:348-56
19. Roberts P, Chumas PD, Picton S, et al. A review of the cytogenetics of 58 pediatric brain tumors. Cancer Genet Cytogenet 2001;131:1-12
20. Sanoudou D, Tingby O, Ferguson-Smith MA, et al. Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 2000;82:1218-22
21. Shlomit R, Ayala AG, Michal D, et al. Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet Cytogenet 2000;121:67-72
22. Szymas J, Wolf G, Peterson S, et al. Comparative genomic hybridisation indicating two distinct subgroups of pilocytic astrocytomas. Neurosurg Focus 2000;8:Clinical Pearl 2
23. White FV, Anthony DC, Yunis EJ, et al. Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. Hum Pathol 1995;26:979-86
24. Zattara-Cannoni H, Gambarelli D, Lena G, et al. Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. Cancer Genet Cytogenet 1998;104:157-60
25. Ichimura K, Schmidt EE, Goike HM, et al. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996;13:1065-72
26. Fiegler H, Carr P, Douglas EJ, et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003;36:361-74
27. McCabe M, Ichimura K, Liu L, et al. High resolution array-based comparative genomic hybridisation of medulloblastomas and supratentorial primitive neuroectodermal tumours. J Neuropathol Exp Neurol, in press
28. Seng TJ, Ichimura K, Liu L, et al. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 2005;43:181-93
29. Ichimura K, Mungall AJ, Fiegler H, et al. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene 2006;25:1261-71
30. Miyakawa A, Ichimura K, Schmidt EE, et al. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours. Br J Cancer 2000;82:543-49
31. Gonzalez-Gomez P, Bello MJ, Lomas J, et al. Epigenetic changes in pilocytic astrocytomas and medulloblastomas. Int J Mol Med 2003;11:655-60
32. Yu J, Zhang H, Gu J, et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer 2004;4:65
33. Harris RL, Harrison CJ, Martineau M, et al. Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia? Cancer Genet Cytogenet 2004;148:159-62
34. Schlegelberger B, Zwingers T, Hohenadel K, et al. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 1996;14:593-99
35. Schlegelberger B, Zwingers T, Harder L, et al. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group. Blood 1999;94:3114-20
36. Terris B, Meddeb M, Marchio A, et al. Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. Genes Chromosomes Cancer 1998;22:50-56
37. Liu L, Ichimura K, Pettersson EH, et al. Chromosome 7 rearrangements in glioblastomas; loci adjacent to EGFR are independently amplified. J Neuropathol Exp Neurol 1998;57:1138-45
38. Ichimura K, Ohgaki H, Kleihues P, et al. Molecular pathogenesis of astrocytic tumours. J Neurooncol 2004;70:137-60
39. Johansson B, Heim S, Mandahl N, et al. Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 1993;6:199-205
40. Heim S, Mandahl N, Jin Y, et al. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet Cell Genet 1989;52:136-38
41. Broberg K, Toksvig-Larsen S, Lindstrand A, et al. Trisomy 7 accumulates with age in solid tumors and non-neoplastic synovia. Genes Chromosomes Cancer 2001;30:310-15
42. Matzke MA, Mette MF, Kanno T, et al. Does the intrinsic instability of aneuploid genomes have a causal role in cancer? Trends Genet 2003;19:253-56
43. Marx J. Debate surges over the origins of genomic defects in cancer. Science 2002;297:544-46
44. Hanks S, Rahman N. Aneuploidy-cancer predisposition syndromes: A new link between the mitotic spindle checkpoint and cancer. Cell Cycle 2005;4:225-27
45. Hirose Y, Aldape KD, Chang S, et al. Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet 2003;142:1-7
46. Misra A, Pellarin M, Nigro J, et al. Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma. Clin Cancer Res 2005;11:2907-18
47. Nigro JM, Misra A, Zhang L, et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 2005;65:1678-86
48. Shiraishi T, Tabuchi K. Genetic alterations of human brain tumors as molecular prognostic factors. Neuropathology 2003;23:95-108
49. Smith JS, Tachibana I, Passe SM, et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001;93:1246-56
50. Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 2004;10:228-33
51. Mahler-Araujo MB, Sanoudou D, Tingby O, et al. Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas. J Neuropathol Exp Neurol 2003;62:927-35
52. Kondo K, Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene. Exp Cell Res 2001;264:117-25
53. Beeram M, Patnaik A, Rowinsky EK. Raf: A strategic target for therapeutic development against cancer. J Clin Oncol 2005;23:6771-90
54. Brantley DM, Cheng N, Thompson EJ, et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 2002;21:7011-26
55. Cesari R, Martin ES, Calin GA, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A 2003;100:5956-61
56. Picchio MC, Martin ES, Cesari R, et al. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res 2004;10:2720-24
57. Wang F, Denison S, Lai JP, et al. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer 2004;40:85-96
58. Mulholland PJ, Fiegler H, Mazzanti C, et al. Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme. Cell Cycle 2006;5:783-91
59. Penfield W. Microglia and the process of phagocytosis in gliomas. Am J Pathol 1925;1:77-97
60. Sasaki A, Yamaguchi H, Horikoshi Y, et al. Expression of glucose transporter 5 by microglia in human gliomas. Neuropathol Appl Neurobiol 2004;30:447-55
61. Wong KK, Chang YM, Tsang YT, et al. Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res 2005;65:76-84